EGF (Epidermal Growth Factor)vsZinc Oxide

EGF binds EGFR/ErbB1 on keratinocytes and fibroblasts, triggering dimerization and autophosphorylation. Activates MAPK/ERK (Ras-Raf-MEK-ERK) and PI3K/AKT pathways, promoting proliferation, migration (actin reorganization, focal adhesion turnover), and differentiation. Upregulates cyclin D1, inhibits p27. Stimulates fibroblast collagen types I/III and hyaluronic acid via HAS2. In wound healing, accelerates re-epithelialization via keratinocyte migration and reduces scarring via TGF-beta modulation. For anti-aging, promotes cellular renewal and extracellular matrix production. Theoretical cancer concern from EGFR's growth role — topical EGF has not been shown to penetrate to basal layer or systemic circulation significantly.

Zinc oxide particles sit on the skin surface and primarily scatter and reflect UV radiation across the full UVA (320–400 nm) and UVB (280–320 nm) spectrum via Rayleigh and Mie scattering. At nano scale, zinc oxide also absorbs UV photons and undergoes semiconductor band-gap excitation, converting UV energy to heat—a mechanism similar to organic chemical filters. It provides the broadest single-ingredient UV coverage available. Beyond photoprotection, zinc oxide exerts anti-inflammatory effects by inhibiting NF-κB activation, reducing pro-inflammatory cytokine release (TNF-α, IL-6), and modulating Toll-like receptor signaling. It supports barrier repair by promoting occludin and zonula occludens-1 expression in tight junctions. Zinc ions have mild antimicrobial activity against Staphylococcus aureus and Candida species. These properties underlie its use in diaper rash creams, wound care, and post-procedure skincare. Zinc oxide does not penetrate intact stratum corneum when formulated as micronized or nano particles.